Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts $8.35 +0.04 (+0.48%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$8.74 +0.39 (+4.67%) As of 08:32 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Avalo Therapeutics Earnings Summary Avalo Therapeutics announced Q1 2025 earnings on May 12, 2025, reporting an EPS of -$1.25, which missed analysts' consensus estimates of -$1.07 by $0.18. With a trailing EPS of $0.00, Avalo Therapeutics' earnings are expected to grow next year, from ($19.07) to ($4.70) per share. Latest Q1 Earnings DateMay. 12EstimatedConsensus EPS (May. 12) -$1.07 Actual EPS (May. 12) -$1.25 Missed By -$0.18 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Quarterly Report (10-Q) Press Release (8-K)Powered by Get Avalo Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avalo Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAVTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AVTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Avalo Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$1.06$0.63-$0.22Q2 20252-$1.25-$1.09-$1.17Q3 20252-$1.31-$1.13-$1.22Q4 20251-$0.79-$0.79-$0.79 FY 2025 7 -$4.41 -$2.38 -$3.40 Q1 20261-$0.79-$0.79-$0.79Q2 20261-$0.83-$0.83-$0.83Q3 20261-$0.86-$0.86-$0.86Q4 20261-$0.66-$0.66-$0.66 Avalo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/12/2025Q1 2025-$1.07-$1.25 -$0.18-$1.25--8/12/2024Q2 2024-$6.70-$14.07 -$7.37-$14.07--5/13/2024Q1 2024-$1.18-$5.98 -$4.80$129.04--11/9/2023Q3 2023-$264.00-$26.40+$237.60-$0.11$1.00M$0.24M Avalo Therapeutics Earnings - Frequently Asked Questions When did Avalo Therapeutics announce their last quarterly earnings? Avalo Therapeutics (NASDAQ:AVTX) last announced its quarterly earning data on Monday, May 12, 2025. Learn more on AVTX's earnings history. Did Avalo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($1.07) by $0.18 with a reported earnings per share (EPS) of ($1.25). Learn more on analysts' earnings estimate vs. AVTX's actual earnings. How much revenue does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $441,000.00. How much profit does Avalo Therapeutics generate each year? Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$35.13 million. AVTX has generated $0.00 earnings per share over the last four quarters. What is Avalo Therapeutics' EPS forecast for next year? Avalo Therapeutics' earnings are expected to grow from ($19.07) per share to ($4.70) per share in the next year. More Earnings Resources from MarketBeat Related Companies Mereo BioPharma Group Earnings Results Alpha Teknova Earnings Results Annexon Earnings Results Lifecore Biomedical Earnings Results Monopar Therapeutics Earnings Results Aurora Cannabis Earnings Results Cardiff Oncology Earnings Results Editas Medicine Earnings Results DBV Technologies Earnings Results Inozyme Pharma Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a RallyRivian Takes Earnings Hit—R2 Could Be the Stock's 2026 LifelinePalantir Stock Soars After Blowout Earnings ReportVertical Aerospace's New Deal and Earnings De-Risk Production This page (NASDAQ:AVTX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
